Drug Trial Radar · NCT07762170
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)
Last checked: Nov 20, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Jul 30, 2026
Primary completion
Dec 2029
Study completion Mar 2030
Sponsor
- Lead sponsor
- Igor Wilderman. MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to analyze the efficacy and safety of different kinds of steroid injections for back pain, comparing different steroids, dosages, locations (epidural, facet joints, nerve blocks), and also the difference between injections with steroids and local anesthetics, to optimize this treatment that is currently not standardized. The investigators will compare retrospectively and prospectively the efficacy of different injections in the same patients, using mainly a parameter called integral of pain relief, which combines the percentage of pain relief provided by a treatment and its duration over time, as well as improvements in functionality.
Conditions
- Back Pain Lower Back
- Neck Pain
- Radiculopathy Multiple Sites
- Spinal Stenosis Cervicothoracic Region
- Spinal Stenosis Lumbar
- Failed Back Surgery Syndrome (FBSS)
- Sciatica
- Intervertebral Disc Disorders With Radiculopathy, Lumbar Region
- Spine Osteoarthritis
Interventions
triamcinolone acetonide (Kenalog)Drug
Comparison of efficacy and safety of various protocols of injections for back pain
Celestone Soluspan 6Mg/Ml Suspension for InjectionDrug
Comparison of efficacy and safety of various protocols of injections for back pain
Depo-Medrol 40Mg/Ml Suspension for InjectionDrug
Comparison of efficacy and safety of various protocols of injections for back pain
DexamethasoneDrug
Comparison of efficacy and safety of various protocols of injections for back pain
Primary outcomes
What the sponsor says the trial is designed to measure.
- Integral of pain reliefTime frame: 8-12 weeks, up to 6 months or one year if applicable
- Numeric rating scaleTime frame: 2, 4, 6, 8, 12 weeks
- Functional integral of pain reliefTime frame: 8-12 weeks, up to 6 months or one year if applicable
- Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaire - custom versionTime frame: 2, 4, 6, 8, 12 weeks
- Patient's global impression of change (PGIC)Time frame: 2, 4, 6, 8, 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Wilderman Medical Clinic
Thornhill, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.